On Tuesday 4 November DDW will be holding its Turning Science into Business Symposium at the Francis Crick Institute in London.

Six in-depth topic presentations from industry experts will be followed by a panel discussion examining new processes and technology, with a focus on how they can create efficiencies and expedite the drug discovery.

Confirmed speakers include:

  • Nikhil Gupta, Principal Scientist at the Cancer Research Horizons- AstraZeneca Functional Genomics Centre.
  • Chas Bountra Pro-Vice-Chancellor for Innovation, Professor of Translational Medicine, Oxford University
  • Lawrence Welch, Inside Sales Specialist, Nuclera

The free half day event will explore upcoming areas of opportunity in drug discovery such as AI-driven drug design, omics and PROTACS, as well as the challenges the industry will face in embracing new these technologies and modalities. Tickets will be allocated on a first come first served basis, according to eligibility.

The event is sponsored by Nuclera (lead sponsor) and Collaborative Drug Discovery (coffee break sponsor).

Register here.

Nikhil Gupta
Nikhil Gupta
Chas Bountra
Chas Bountra
Lawrence Welch
Lawrence Welch